Keyphrases
Tuberculosis
100%
Texas
49%
Alzheimer's Disease
47%
Mycobacterium Tuberculosis (M. tb)
43%
United States
33%
Older Adults
32%
Latent Tuberculosis Infection
27%
Tuberculosis Treatment
25%
Atherosclerosis Prevention
24%
Air Force
24%
Coronary Atherosclerosis
24%
Prevention Studies
24%
Lovastatin
23%
High-density Lipoprotein Cholesterol (HDL-C)
20%
Tuberculosis Patients
19%
Confidence Interval
19%
Heart Rate
18%
Rifapentine
18%
Pulmonary Tuberculosis
18%
Cholesterol
17%
Mild Cognitive Impairment
16%
Low-density Lipoprotein Cholesterol (LDL-C)
16%
Directly Observed Therapy
15%
Pulmonary Dysfunction
15%
Placebo
15%
Geriatrics
14%
CD8+ T Cells
14%
Tuberculin Skin Test
13%
Aging
13%
Antiretroviral Therapy
13%
Statin Therapy
12%
Tuberculosis Diagnosis
12%
Mexican Americans
12%
T Cells
12%
Dementia
11%
Odds Ratio
11%
Major Coronary Events
11%
HIV Patients
11%
High Risk
11%
Age-friendly Care
10%
Risk Factors
10%
Elderly People
10%
Primary Prevention
10%
Osteopathy
10%
Geriatric Education
10%
Relative Risk
10%
Statins
9%
Cerebral Perfusion
9%
Elderly Patients
9%
Mean Arterial Pressure
9%
Neuropsychiatric Symptoms
9%
Gemfibrozil
9%
Cardiorespiratory Responses
9%
Fall Prevention
9%
Intervention Group
9%
HIV Infection
8%
Age-friendly
8%
Multidrug-resistant Tuberculosis (MDR-TB)
8%
Mentation
8%
Health Care Costs
8%
Once-weekly
8%
Canada
8%
LDL Cholesterol
8%
CD4+
7%
Older Persons
7%
Osteopathic
7%
Treatment Completion
7%
Treatment Group
7%
AIDS/HIV
7%
CD4 Count
7%
Low-density Lipoprotein Cholesterol Level
7%
Physical Therapy Students
7%
Immunosuppressive Therapy
7%
Primary Care
7%
Genotype
7%
Randomized Clinical Trial
7%
Intracellular Pathogen
7%
Drug Resistance
7%
Geriatric Workforce
7%
Adverse Events
7%
Acute Coronary Event
6%
Pathophysiology
6%
Age-Friendly Health Systems
6%
Tolerability
6%
Older Patients
6%
CVLT-II
6%
IS6110
6%
Immunization
6%
Elderly Adults
6%
Tuberculosis Control
6%
Cognitive Decline
6%
Monocytes
6%
SMART Study
6%
Clinical Outcomes
6%
Older Women
6%
Mycobacterium Tuberculosis Infection
6%
Muscle Symptoms
6%
HIV-related
6%
Experiential Learning Activities
6%
C-reactive Protein
6%
Medicine and Dentistry
Disease
35%
Tuberculosis
32%
Human Immunodeficiency Virus
27%
Geriatrics
19%
Lung Tuberculosis
18%
Health Care Cost
17%
Primary Health Care
16%
Mycobacterium Tuberculosis
15%
Drug Therapy
15%
Latent Tuberculosis
14%
Lovastatin
13%
Directly Observed Therapy
12%
Placebo
11%
Tuberculosis Treatment
10%
Brain Perfusion
9%
Fall Prevention
9%
Cardiorespiratory
9%
Primary Prevention
8%
Prevalence
8%
Mean Arterial Pressure
8%
Low Density Lipoprotein Cholesterol
7%
Isoniazid
7%
Restriction Fragment Length Polymorphism
7%
Pathogen
7%
Quality Improvement
7%
High Density Lipoprotein Cholesterol
7%
Intermittent Hypoxia
7%
Clinical Trial
7%
Alzheimer's Disease
7%
Foreign Born
7%
Elderly Patient
6%
Mini-Mental State Examination
6%
Mild Cognitive Impairment
6%
Immigrant
6%
Breathing Rate
6%
Health System
6%
Elderly Population
6%
Tuberculin
6%
Hypoxemia
6%
Hypoxia
6%
Odds Ratio
6%
Anus Carcinoma
6%
Drug Resistance
6%
T Cell
6%
Gastroesophageal Reflux
6%
Pathophysiology
6%
Skin Test
6%
Ingestion
6%
Hypotension
6%
Triage
6%
Glycemic Control
6%
Maturity Onset Diabetes of the Young
6%
Lung
6%
Cell Count
6%
Patient Care
5%
Short Term Memory
5%
Promoter Region
5%
Infectious Disease Treatment
5%
Mantoux Test
5%
Middle Cerebral Artery
5%